Related Experiment Video
Updated: May 2, 2026

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
Published on: February 28, 2019
Astragalin inhibits hepatitis B virus through functional reconstitution of CD8+ T cells and a direct effect on HBV
Haohao Li1, Shasha Yang1, Huajun Zhao1
1State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, School of Pharmaceutical Sciences, Shandong University, Jinan, Shandong, China.
Persistent HBV infection promotes hepatic lipid accumulation, a feature linked to immune dysfunction. We found cytotoxic T lymphocytes (CD8+ T cells) from chronic HBV infection (CHB) patients exhibited elevated lipid peroxidation in response to hepatic lipids accumulation. And lipid peroxidation drives CD8+ T cell dysfunction. Astragalin (AG), a natural active compound from Chinese herbs, reduced lipid peroxidation. Mechanically, AG upregulated Glutathione peroxidase 4 (GPX4) expression, protecting CD8+ T cells against membrane lipid peroxidation and reversing their exhaustion during chronic HBV infection. Importantly, AG significantly reduced circulating serum HBsAg and HBV DNA levels in HBV-carrier mice. Furthermore, AG directly reduced HBsAg, HBeAg and HBV RNA levels in HepG2.2.15 cells and significantly induced expression of the interferon-inducible antiviral protein myxovirus resistance protein A (MxA). In conclusion, AG exhibits dual anti-HBV activity by enhancing CD8+ T cell antiviral function and directly suppressing HBV replication, holding promise as a potential candidate for the treatment of chronic HBV infection.
Persistent HBV infection promotes hepatic lipid accumulation, a feature linked to immune dysfunction. We found cytotoxic T lymphocytes (CD8+ T cells) from chronic HBV infection (CHB) patients exhibited elevated lipid peroxidation in response to hepatic lipids accumulation. And lipid peroxidation drives CD8+ T cell dysfunction. Astragalin (AG), a natural active compound from Chinese herbs, reduced lipid peroxidation. Mechanically, AG upregulated Glutathione peroxidase 4 (GPX4) expression, protecting CD8+ T cells against membrane lipid peroxidation and reversing their exhaustion during chronic HBV infection. Importantly, AG significantly reduced circulating serum HBsAg and HBV DNA levels in HBV-carrier mice. Furthermore, AG directly reduced HBsAg, HBeAg and HBV RNA levels in HepG2.2.15 cells and significantly induced expression of the interferon-inducible antiviral protein myxovirus resistance protein A (MxA). In conclusion, AG exhibits dual anti-HBV activity by enhancing CD8+ T cell antiviral function and directly suppressing HBV replication, holding promise as a potential candidate for the treatment of chronic HBV infection.
Related Concept Videos
Hepatitis
Inhibitors of Viral Protein Synthesis
Viral Hepatitis I: Introduction

